Poklar, N, Pilch, D S, Lippard, S J, Redding, E A, Dunham, S U, Breslauer, K J
cis-Diamminedichloroplatinum(II) (cisplatin) is a widely used anticancer drug that binds to and crosslinks DNA. The major DNA adduct of the drug results from coordination of two adjacent guanine...
Huang, J C, Zamble, D B, Reardon, J T, Lippard, S J, Sancar, A
The most frequent DNA adduct made by the anticancer drug cisplatin, the 1,2-intrastrand d(GpG) cross-link, as well as the minor 1,3-intrastrand d(GpTpG) adduct, were both repaired by an in vitro...
High-mobility-group 1 protein mediates DNA bending as determined by ring closures.
Pil, P M, Chow, C S, Lippard, S J
High-mobility-group 1 protein (HMG1) is an abundant eukaryotic DNA-binding protein, the cellular role of which remains ill-defined. To test the ability of HMG1 itself to mediate curvature in...
Bruhn, S L, Pil, P M, Essigmann, J M, Housman, D E, Lippard, S J
Human cDNA clones encoding a structure-specific recognition protein, SSRP1, that binds specifically to DNA modified with cisplatin have been isolated and characterized. The SSRP1 gene maps to human...
Szymkowski, D E, Yarema, K, Essigmann, J M, Lippard, S J, Wood, R D
We have examined the ability of human cell extracts to repair the most frequent DNA adduct caused by the cancer chemotherapeutic agent cis-diamminedichloroplatinum(II). A circular DNA duplex with an...
Rice, J A, Crothers, D M, Pinto, A L, Lippard, S J
We used gel electrophoresis methods to show that reaction of DNA with cis-diamminedichloroplatinum(II) results in a substantial (approximately equal to 40 degrees) bend in the double helix at the...
Toney, J H, Donahue, B A, Kellett, P J, Bruhn, S L, Essigmann, J M, Lippard, S J
DNA modified by the antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP or cisplatin) was used to identify a factor in mammalian cells that binds to cis-DDP-damaged DNA and hence may play a role...
Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
Sundquist, W I, Lippard, S J, Stollar, B D
Murine monoclonal antibodies that bind selectively to adducts formed on DNA by the antitumor drug cis-diamminedichloroplatinum(II), cis-DDP, or to the chemotherapeutically inactive trans isomer...
Yarema, K J, Lippard, S J, Essigmann, J M
The toxicity and mutagenicity of three DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II) (cis-DDP or cisplatin) were investigated in Escherichia coli. The adducts studied...
Bruhn, S L, Housman, D E, Lippard, S J
Recently an HMG-box protein denoted SSRP1, for structure-specific recognition protein 1, has been discovered which binds to specific DNA structural elements such as the bent, unwound conformations...
Ushay, H M, Santella, R M, Caradonna, J P, Grunberger, D, Lippard, S J
Chlorodiethylenetriamineplatinum(II) chloride, [(dien)PtCl]Cl, bound to less than or equal to 10% of the nucleotide bases of poly(dG-dC) . poly(dG-dC) reduces the amount of ethanol necessary to bring...
Exonuclease III has been shown previously to reveal the binding sites of the antitumor drug cis-diamminedichloroplatinum(II) on DNA. Pretreatment of the same DNA with the intercalator ethidium...
Poirier, M C, Lippard, S J, Zwelling, L A, Ushay, H M, Kerrigan, D, Thill, C C, ...
Rabbit antiserum elicited against calf thymus DNA modified to 4.4% (Pt drug/nucleotide ratio = 0.044) with the antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP) contains antibodies specific...
Bond, P J, Langridge, R, Jennette, K W, Lippard, S J
Good quality x-ray diffraction patterns have been obtained of polycrystalline fibers containing 2-hydroxyethanethiolato(2,2'2"-terpyridine)platinum(II) bound to calf thymus DNA by intercalation. The...
Mascharak, P K, Sugiura, Y, Kuwahara, J, Suzuki, T, Lippard, S J
The antitumor drug cis-diamminedichloroplatinum(II) dramatically alters the sequence-specific cleavage of the bleomycin A2-iron(II)-O2 system. Preferred bleomycin cleavage sites adjacent to oligo(dG)...
Inhibition of DNA replication by the antitumor drug cis-diamminedichloroplatinum (II) (cis-DDP) has been proposed to be responsible for its cytotoxicity. Treatment of primed phage M13 mp8 viral DNA...
Tetrakis(acetoxymercuri)methane: a polymetallic reagent for labeling sulfur in nucleic acids.
Strothkamp, K G, Lehmann, J, Lippard, S J
Tetrakis(acetoxymercuri)methane binds to the sulfur atom of 6-thioguanosine and also to the 4-thiouridine residue of Escherichia coli tRNAVal. A 4:1 complex is formed between 6-thioguanosine and...
Platinum binding to nucleoside phosphorothioates has been examined to determine their suitability as heavy metal labeling sites for the potential electron microscopic sequencing of nucleic acids. The...
Jennette, K. W., Lippard, S. J., Vassiliades, G. A., Bauer, W. R.
The red, cationic complex 2-hydroxy-ethanethiolato(2,2′,2″-terpyridine)platinum(II), [(terpy)-Pt(SCH2CH2OH)]+, binds strongly to DNA by a mechanism involving intercalation. By means of...
Poklar, N, Pilch, D S, Lippard, S J, Redding, E A, Dunham, S U, Breslauer, K J
cis-Diamminedichloroplatinum(II) (cisplatin) is a widely used anticancer drug that binds to and crosslinks DNA. The major DNA adduct of the drug results from coordination of two adjacent guanine...
Huang, J C, Zamble, D B, Reardon, J T, Lippard, S J, Sancar, A
The most frequent DNA adduct made by the anticancer drug cisplatin, the 1,2-intrastrand d(GpG) cross-link, as well as the minor 1,3-intrastrand d(GpTpG) adduct, were both repaired by an in vitro...
High-mobility-group 1 protein mediates DNA bending as determined by ring closures.
Pil, P M, Chow, C S, Lippard, S J
High-mobility-group 1 protein (HMG1) is an abundant eukaryotic DNA-binding protein, the cellular role of which remains ill-defined. To test the ability of HMG1 itself to mediate curvature in...
Bruhn, S L, Pil, P M, Essigmann, J M, Housman, D E, Lippard, S J
Human cDNA clones encoding a structure-specific recognition protein, SSRP1, that binds specifically to DNA modified with cisplatin have been isolated and characterized. The SSRP1 gene maps to human...
Szymkowski, D E, Yarema, K, Essigmann, J M, Lippard, S J, Wood, R D
We have examined the ability of human cell extracts to repair the most frequent DNA adduct caused by the cancer chemotherapeutic agent cis-diamminedichloroplatinum(II). A circular DNA duplex with an...
Rice, J A, Crothers, D M, Pinto, A L, Lippard, S J
We used gel electrophoresis methods to show that reaction of DNA with cis-diamminedichloroplatinum(II) results in a substantial (approximately equal to 40 degrees) bend in the double helix at the...
Toney, J H, Donahue, B A, Kellett, P J, Bruhn, S L, Essigmann, J M, Lippard, S J
DNA modified by the antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP or cisplatin) was used to identify a factor in mammalian cells that binds to cis-DDP-damaged DNA and hence may play a role...
Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
Sundquist, W I, Lippard, S J, Stollar, B D
Murine monoclonal antibodies that bind selectively to adducts formed on DNA by the antitumor drug cis-diamminedichloroplatinum(II), cis-DDP, or to the chemotherapeutically inactive trans isomer...
Yarema, K J, Lippard, S J, Essigmann, J M
The toxicity and mutagenicity of three DNA adducts formed by the anticancer drug cis-diamminedichloroplatinum(II) (cis-DDP or cisplatin) were investigated in Escherichia coli. The adducts studied...
Bruhn, S L, Housman, D E, Lippard, S J
Recently an HMG-box protein denoted SSRP1, for structure-specific recognition protein 1, has been discovered which binds to specific DNA structural elements such as the bent, unwound conformations...
Ushay, H M, Santella, R M, Caradonna, J P, Grunberger, D, Lippard, S J
Chlorodiethylenetriamineplatinum(II) chloride, [(dien)PtCl]Cl, bound to less than or equal to 10% of the nucleotide bases of poly(dG-dC) . poly(dG-dC) reduces the amount of ethanol necessary to bring...
Exonuclease III has been shown previously to reveal the binding sites of the antitumor drug cis-diamminedichloroplatinum(II) on DNA. Pretreatment of the same DNA with the intercalator ethidium...
Poirier, M C, Lippard, S J, Zwelling, L A, Ushay, H M, Kerrigan, D, Thill, C C, ...
Rabbit antiserum elicited against calf thymus DNA modified to 4.4% (Pt drug/nucleotide ratio = 0.044) with the antitumor drug cis-diamminedichloroplatinum(II) (cis-DDP) contains antibodies specific...
Bond, P J, Langridge, R, Jennette, K W, Lippard, S J
Good quality x-ray diffraction patterns have been obtained of polycrystalline fibers containing 2-hydroxyethanethiolato(2,2'2"-terpyridine)platinum(II) bound to calf thymus DNA by intercalation. The...
Mascharak, P K, Sugiura, Y, Kuwahara, J, Suzuki, T, Lippard, S J
The antitumor drug cis-diamminedichloroplatinum(II) dramatically alters the sequence-specific cleavage of the bleomycin A2-iron(II)-O2 system. Preferred bleomycin cleavage sites adjacent to oligo(dG)...
Inhibition of DNA replication by the antitumor drug cis-diamminedichloroplatinum (II) (cis-DDP) has been proposed to be responsible for its cytotoxicity. Treatment of primed phage M13 mp8 viral DNA...
Tetrakis(acetoxymercuri)methane: a polymetallic reagent for labeling sulfur in nucleic acids.
Strothkamp, K G, Lehmann, J, Lippard, S J
Tetrakis(acetoxymercuri)methane binds to the sulfur atom of 6-thioguanosine and also to the 4-thiouridine residue of Escherichia coli tRNAVal. A 4:1 complex is formed between 6-thioguanosine and...
Platinum binding to nucleoside phosphorothioates has been examined to determine their suitability as heavy metal labeling sites for the potential electron microscopic sequencing of nucleic acids. The...
Jennette, K. W., Lippard, S. J., Vassiliades, G. A., Bauer, W. R.
The red, cationic complex 2-hydroxy-ethanethiolato(2,2′,2″-terpyridine)platinum(II), [(terpy)-Pt(SCH2CH2OH)]+, binds strongly to DNA by a mechanism involving intercalation. By means of...